and we are well within that late first half time period. Stool Bacterial Pathogens Panel approval soon imo. Will put them at 6 FDA approvals which is significant to compete with the larger players in this space. Also incremental revenue from existing clients.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.